Keith A. Goldan insider trades: Syndax Pharmaceuticals (SNDX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Keith reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | SNDX | ↓ Sell | 1,177 | $18.99 | $22K | Direct | Jun 2, 2026 (1d) |
| Feb 9, 2026 | SNDX | ↓ Sell | 3,410 | $21.03 | $72K | Direct | Feb 10, 2026 (1d) |
| Feb 6, 2026 | SNDX | ↓ Sell | 2,082 | $20.62 | $43K | Direct | Feb 6, 2026 (0d) |
| Jul 16, 2025 | SNDX | ↓ Sell | 1,296 | $9.29 | $12K | Direct | Jul 18, 2025 (2d) |
| Feb 10, 2025 | SNDX | ↓ Sell | 3,777 | $15.50 | $59K | Direct | Feb 12, 2025 (2d) |
| Jun 14, 2024 | SNDX | ↑ Buy | 1,250 | $20.03 | $25K | Direct | Jun 17, 2024 (3d) |
| Jun 13, 2023 | SNDX | ↓ Sell | 577 | $22.31 | $13K | Direct | Jun 14, 2023 (1d) |
| Mar 16, 2022 | OPTN | ↓ Sell | 4,617 | $2.11 | $10K | Direct | Mar 17, 2022 (1d) |
| Dec 16, 2021 | OPTN | ↓ Sell | 580 | $1.64 | $951 | Direct | Dec 17, 2021 (1d) |
| Sep 16, 2021 | OPTN | ↓ Sell | 578 | $2.79 | $2K | Direct | Sep 17, 2021 (1d) |
| Jun 17, 2021 | OPTN | ↓ Sell | 576 | $3.73 | $2K | Direct | Jun 17, 2021 (0d) |
| Mar 15, 2021 | OPTN | ↓ Sell | 2,304 | $3.92 | $9K | Direct | Mar 17, 2021 (2d) |
| Sep 23, 2020 | OPTN | ↑ Buy | 2,500 | $3.90 | $10K | Direct | Sep 23, 2020 (0d) |
| Aug 11, 2015 | FCSC | ↑ Buy | 2,000 | $6.33 | $13K | Direct | Aug 11, 2015 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SNDX insiders
Open-market trades in the last 12 months
About Keith A. Goldan's insider trades
Keith A. Goldan is Chief Financial Officer at Syndax Pharmaceuticals (SNDX). Since Aug 11, 2015, Keith has reported 3 open-market purchases worth $47K and 11 sales worth $244K on SEC Form 4. In the last 12 months: 3 sales ($137K).
Their filings also include grants and awards (16 filings), other transactions (4 filings), shares returned to the company (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.